Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Blake J Cochran

Showing results (1-10 of 51) with videos related to

Pageof 6
Sort By:
Journal of the American Heart Association|January 1, 2020
Role of High-Density Lipoproteins in Cholesterol Homeostasis and Glycemic ControlBikash Manandhar, Blake J Cochran, Kerry-Anne Rye
Advances in Experimental Medicine and Biology|May 16, 2022
HDL and DiabetesBlake J Cochran, Bikash Manandhar, Kerry-Anne Rye
Cells|July 2, 2021
Inflammation during Percutaneous Coronary Intervention-Prognostic Value, Mechanisms and Therapeutic TargetsBradley Tucker, Kaivan Vaidya, Blake J Cochran, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|June 29, 2023
ApoA-I and DiabetesThomas W King, Blake J Cochran, Kerry-Anne Rye
Current Opinion in Lipidology|December 15, 2015
Apolipoprotein A-I interactions with insulin secretion and productionKerry-Anne Rye, Philip J Barter, Blake J Cochran
Atherosclerosis|October 3, 2018
CETP inhibition, statins and diabetesPhilip J Barter, Blake J Cochran, Kerry-Anne Rye
Seminars in Thrombosis and Hemostasis|August 2, 2011
Forty years later and the role of plasminogen activator inhibitor type 2/SERPINB2 is still an enigmaJodi A Lee, Blake J Cochran, Sergei Lobov, et al.
Cells|April 30, 2021
High Density Lipoproteins and DiabetesBlake J Cochran, Kwok-Leung Ong, Bikash Manandhar, et al.
Current Atherosclerosis Reports|February 16, 2021
APOA1: a Protein with Multiple Therapeutic FunctionsBlake J Cochran, Kwok-Leung Ong, Bikash Manandhar, et al.
Frontiers in Cardiovascular Medicine|July 18, 2022
Inhibition of Vascular Inflammation by Apolipoprotein A-IVKate Shearston, Joanne T M Tan, Blake J Cochran, et al.
Pageof 6

Showing results (1-10 of 51) with videos related to

Sort By:
Pageof 6
Journal of the American Heart Association|January 1, 2020
Role of High-Density Lipoproteins in Cholesterol Homeostasis and Glycemic ControlBikash Manandhar, Blake J Cochran, Kerry-Anne Rye
Advances in Experimental Medicine and Biology|May 16, 2022
HDL and DiabetesBlake J Cochran, Bikash Manandhar, Kerry-Anne Rye
Cells|July 2, 2021
Inflammation during Percutaneous Coronary Intervention-Prognostic Value, Mechanisms and Therapeutic TargetsBradley Tucker, Kaivan Vaidya, Blake J Cochran, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|June 29, 2023
ApoA-I and DiabetesThomas W King, Blake J Cochran, Kerry-Anne Rye
Current Opinion in Lipidology|December 15, 2015
Apolipoprotein A-I interactions with insulin secretion and productionKerry-Anne Rye, Philip J Barter, Blake J Cochran
Atherosclerosis|October 3, 2018
CETP inhibition, statins and diabetesPhilip J Barter, Blake J Cochran, Kerry-Anne Rye
Seminars in Thrombosis and Hemostasis|August 2, 2011
Forty years later and the role of plasminogen activator inhibitor type 2/SERPINB2 is still an enigmaJodi A Lee, Blake J Cochran, Sergei Lobov, et al.
Cells|April 30, 2021
High Density Lipoproteins and DiabetesBlake J Cochran, Kwok-Leung Ong, Bikash Manandhar, et al.
Current Atherosclerosis Reports|February 16, 2021
APOA1: a Protein with Multiple Therapeutic FunctionsBlake J Cochran, Kwok-Leung Ong, Bikash Manandhar, et al.
Frontiers in Cardiovascular Medicine|July 18, 2022
Inhibition of Vascular Inflammation by Apolipoprotein A-IVKate Shearston, Joanne T M Tan, Blake J Cochran, et al.
Pageof 6